Abiopharma

Health Catalyst Announces Upfront: Market Insights on Salesforce AppExchange

Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

Initial Data Shows 100% Disease Control in 5 Out of 5 Patients With Recurrent Glioblastoma With Two Patients in Near Complete Response Treated With ImmunityBio’s ANKTIVA®, NK Cell Therapy Plus Optune Gio® Device

DexCom, Inc. - Dexcom Announces Upcoming Conference Presentations

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Dexcom Announces Upcoming Conference Presentations

Director WEHRWEIN SVEN 🟡 adjusted position in 5.0K shares (1 derivative) of AtriCure, Inc. (ATRC) at $37.00 Transaction Date: Aug 22, 2025 | Filing ID: 000005

New Form SC 14D9/A - DURECT CORP Filed: 2025-08-26 AccNo: 0001193125-25-188167 Size: 22 KB

New Form S-8 - Quoin Pharmaceuticals, Ltd. Filed: 2025-08-25 AccNo: 0001104659-25-082553 Size: 267 KB

KIRK THOMAS F 🟢 acquired 50.0K shares of MYOMO, INC. (MYO) at $1.15 Transaction Date: Aug 25, 2025 | Filing ID: 000004

Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress

Adagene to Participate in Two Investor Conferences in September

Inovio - INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults